Back to Search Start Over

3D pCASL-perfusion in preoperative assessment of brain gliomas in large cohort of patients.

Authors :
Batalov AI
Zakharova NE
Pronin IN
Belyaev AY
Pogosbekyan EL
Goryaynov SA
Bykanov AE
Tyurina AN
Shevchenko AM
Solozhentseva KD
Nikitin PV
Potapov AA
Source :
Scientific reports [Sci Rep] 2022 Feb 08; Vol. 12 (1), pp. 2121. Date of Electronic Publication: 2022 Feb 08.
Publication Year :
2022

Abstract

The aim of the study was to evaluate the role of pseudocontinuous arterial spin labeling perfusion (pCASL-perfusion) in preoperative assessment of cerebral glioma grades. The study group consisted of 253 patients, aged 7-78 years with supratentorial gliomas (65 low-grade gliomas (LGG), 188 high-grade gliomas (HGG)). We used 3D pCASL-perfusion for each patient in order to calculate the tumor blood flow (TBF). We obtained maximal tumor blood flow (maxTBF) in small regions of interest (30 ± 10 mm <superscript>2</superscript> ) and then normalized absolute maximum tumor blood flow (nTBF) to that of the contralateral normal-appearing white matter of the centrum semiovale. MaxTBF and nTBF values significantly differed between HGG and LGG groups (p < 0.001), as well as between patient groups separated by the grades (grade II vs. grade III) (p < 0.001). Moreover, we performed ROC-analysis which demonstrated high sensitivity and specificity in differentiating between HGG and LGG. We found significant differences for maxTBF and nTBF between grade III and IV gliomas, however, ROC-analysis showed low sensitivity and specificity. We did not observe a significant difference in TBF for astrocytomas and oligodendrogliomas. Our study demonstrates that 3D pCASL-perfusion as an effective diagnostic tool for preoperative differentiation of glioma grades.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2045-2322
Volume :
12
Issue :
1
Database :
MEDLINE
Journal :
Scientific reports
Publication Type :
Academic Journal
Accession number :
35136119
Full Text :
https://doi.org/10.1038/s41598-022-05992-4